<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131-marinedrugs-17-00374" class="ref">
 <label class="label">131.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Joossens</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">De Preter</surname>
    <given-names class="given-names">V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ballet</surname>
    <given-names class="given-names">V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Verbeke</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rutgeerts</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Vermeire</surname>
    <given-names class="given-names">S.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohnâ€™s disease: Results from a double-blinded randomised controlled trial</article-title>
  <source class="source">Gut</source>
  <year class="year">2012</year>
  <volume class="volume">61</volume>
  <fpage class="fpage">958</fpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1136/gutjnl-2011-300413</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">21749983</pub-id>
 </element-citation>
</ref>
